🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetic (PK) profile of tralokinumab (CAT-354) will be studied ...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01592396
Treatments Being Tested
To compare bioavailability and pharmacokinetics of CAT-354 following subcut...
Status
Completed
Location
MDS Pharma Services (US) Inc.
Start Date
2008-04-11
Trial ID
NCT00638989
Treatments Being Tested
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2017-06-12
Trial ID
NCT03160885
Treatments Being Tested
A 52-Week, Open-Label, Multicentre Study to Evaluate the Safety of Tralokin...
Status
Terminated
Location
Research Site
Start Date
2016-11-11
Trial ID
NCT02902809
Treatments Being Tested
The purpose of this trial is to evaluate the efficacy and safety of traloki...
Status
Completed
Location
LEO Pharma Investigator
Start Date
2022-01-13
Trial ID
NCT05194540
Treatments Being Tested
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Celerion
Start Date
2014-03-19
Trial ID
NCT02085473
Treatments Being Tested
This is a Phase 2a, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Research Site
Start Date
2009-06
Trial ID
NCT00873860
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The purpose of this study is to determine whether the addition of tralokinu...
Status
Completed
Location
Research Site
Start Date
2011-08
Trial ID
NCT01402986
Treatments Being Tested
Effects of tralokinumab treatment of atopic dermatitis on skin barrier func...
Status
Completed
Location
UKSH, Campus Kiel
Start Date
2020-09-28
Trial ID
NCT04556461
Treatments Being Tested